The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks
Open accessAbstract
In 459 migraine attacks, information provided to patients (from negative to neutral to positive) modified placebo and medication outcomes in a progressive fashion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a clinical setting, it has been demonstrated that either or both placebo (positive expectancy of pain relief) and nocebo effects (negative expectancy of increased pain) influence the effectiveness of medical treatment (Kam-Hansen et al., 2014; Pollo et al., 2001).”
From Distinct neural representations of placebo and nocebo effects (2015) · cites this paper as Kam-Hansen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Headache Disorders: 2nd edition
Olesen, J., Goadsby, P. J., & Steiner, T. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00590-8 · Cited by 5,046
Biological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F. G., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,309
Self-citationResponse expectancy as a determinant of experience and behavior.
Kirsch, I. (1985) · American Psychologist · doi:10.1037/0003-066x.40.11.1189 · Cited by 1,014
Self-citationPlacebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015591 · Cited by 900 · cited 1×
“A therapeutic benefit of open-label placebo versus no treatment was also recently reported for patients with irritable bowel syndrome in a randomized controlled study (8) and in a pilot study in depression (9).”
BackgroundSelf-citationBenedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04315.2003 · Cited by 788
Overt versus covert treatment for pain, anxiety, and Parkinson's disease
Colloca, L., Lopiano, L., Lanotte, M., & Benedetti, F. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00908-1 · Cited by 565
Social and behavioral consequences of alcohol consumption and expectancy: A meta-analysis.
Hull, J. G., & Bond, C. F. (1986) · Psychological Bulletin · doi:10.1037/0033-2909.99.3.347 · Cited by 502
Response expectancies in placebo analgesia and their clinical relevance
Pollo, A., Amanzio, M., Arslanian, A., Casadio, C., Maggi, G., & Benedetti, F. (2001) · Pain · doi:10.1016/s0304-3959(01)00296-2 · Cited by 442
Response variability to analgesics: a role for non-specific activation of endogenous opioids
Amanzio, M., Pollo, A., Maggi, G., & Benedetti, F. (2001) · Pain · doi:10.1016/s0304-3959(00)00486-3 · Cited by 429
Curran, V. H., Brignell, C. M., Fletcher, S., Middleton, P. M., & Henry, J. A. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1169-0 · Cited by 370
Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease
Lidstone, S. C., Schulzer, M., Dinelle, K., Mak, E., Sossi, V., Ruth, T. J., de la Fuente‐Fernández, R., Phillips, A. G., & Stoessl, A. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.88 · Cited by 325
Nonconscious activation of placebo and nocebo pain responses
Jensen, K. B., Kaptchuk, T. J., Kirsch, I., Raicek, J., Lindstrom, K. M., Berna, C., Gollub, R. L., Ingvar, M., & Kong, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202056109 · Cited by 305
Self-citationOpen-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled Trial
Kelley, J. M., Kaptchuk, T. J., Cusin, C., Lipkin, S., & D, M. F. M. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000337053 · Cited by 190
Self-citationKaptchuk, T. J. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0385 · Cited by 185
Self-citationKaptchuk, T. J., Shaw, J. E., Kerr, C. E., Conboy, L. A., Kelley, J. M., Csordas, T. J., Lembo, A. J., & Jacobson, E. (2009) · Culture Medicine and Psychiatry · doi:10.1007/s11013-009-9141-7 · Cited by 165
Self-citationMetrik, J., Kahler, C. W., Reynolds, B. A., McGeary, J. E., Monti, P. M., Haney, M., de Wit, H., & Rohsenow, D. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2740-y · Cited by 151
Wise, R. A., Bartlett, S. J., Brown, E. D., Castro, M., Cohen, R. I., Holbrook, J. T., Irvin, C. G., Rand, C. S., Sockrider, M. M., & Sugar, E. A. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.041 · Cited by 109
Bergmann, J., Chassany, O., Gandiol, J., Deblois, P., Ja, K., Jm, S., Caulin, C., & Dahan, R. (1994) · PubMed · Cited by 100
Volkow, N., Wang, G.-J., Ma, Y.-M., Fowler, J., Wong, C. T., Jayne, M., Telang, F., & Swanson, J. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.04.192 · Cited by 100
Mitchell, S. H., Jarzyna, C. L., & de Wit, H. (1996) · Psychopharmacology · doi:10.1007/bf02246020 · Cited by 85
Expectation requires treatment to boost pain relief: An fMRI study
Schenk, L. A., Sprenger, C., Geuter, S., & Büchel, C. (2013) · Pain · doi:10.1016/j.pain.2013.09.024 · Cited by 77
Cited by
Sorted by citations
The neuroscience of placebo effects: connecting context, learning and health
Wager, T. D., & Atlas, L. Y. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3976 · Cited by 844
(2020) · doi:10.1056/nejmra1907805 · Cited by 634
Kaptchuk, T. J., & Miller, F. G. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1504023 · Cited by 500
Self-citationCalcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Russo, A. F. (2014) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124701 · Cited by 403
Efficacy and safety of eptinezumab in patients with chronic migraine
Lipton, R. B., Goadsby, P. J., Smith, J., Schaeffler, B. A., Biondi, D. M., Hirman, J., Pederson, S. M., Allan, B., & Cady, R. K. (2020) · Neurology · doi:10.1212/wnl.0000000000009169 · Cited by 404
Metadata
- Authors
- Kam-Hansen, S., Jakubowski, M., Kelley, J. M., Kirsch, I., Hoaglin, D. C., Kaptchuk, T. J., & Burstein, R.
- Affiliations
- Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
- Beth Israel Deaconess Medical Center (US)
- IC Independent Consulting (Australia) (AU)
- Corresponding author
- Kaptchuk, Ted J.
- Burstein, Rami
- Venue
- Science Translational Medicine
- Published
- 2014-01-08
- Volume
- 6
- Issue
- 218
- Pages
- 218ra5-218ra5
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC4005597
- OpenAlex
- W2169836118
- Cited by
- 399
- References
- 22
- Citations by year
- 2026: 11 · 2025: 26 · 2024: 21 · 2023: 26 · 2022: 28 · 2021: 38 · 2020: 47 · 2019: 38 · 2018: 42 · 2017: 36 · 2016: 27 · 2015: 29 · 2014: 29
- FWCI
- 22.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS069847, R37NS079678)
- National Center for Complementary and Integrative Health (K24AT004095)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Health Sciences › Medicine › Complementary and alternative medicine › Acupuncture Treatment Research Studies
- Keywords
- episodic migraine, placebo effect, drug labeling, rizatriptan, patient information, analgesia
- MeSH terms
- Drug Labeling, Humans, Migraine Disorders, Pain Measurement, Placebos, Triazoles, Tryptamines, Treatment Outcome, Endpoint Determination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
